DRKS00008579招募中不适用
Follow-up investigation of former patients of a rehabilitation center (Leppermühle) with the diagnosis of adolescent schizophrenia - Leppermühle catamnesis
niversitätsklinikum Freiburg, Klinik für Psychiatrie, Psychotherapie und Psychosomatik im Kindes- und Jugendalter0 个研究点目标入组 105 人开始时间: 2015年7月13日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 105
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •children and Youngsters suffering from a schizophrenic psychosis, treated in the period from the 01.01.2002 to the 31.12.2004 in the child and youth home Leppermühle.
排除标准
- •F20.6. Schizophrenia simplex, because the reliability and validity of this diagnosis is discussed very controverse.
研究者
相似试验
已完成
不适用
It is the study for analysis of patients of carcinoma esophagus and gastroesophageal junction who have received chemotherapy before.CTRI/2014/08/004839ot applicable31
招募中
1 期
ong-Term Follow-Up of TX200-TR101 (STEADFAST Long Term)Kidney Transplant RejectionMedDRA version: 21.1Level: LLTClassification code: 10050436Term: Prophylaxis against renal transplant rejection Class: 10042613CTIS2024-512580-31-00Sangamo Therapeutics France30
尚未招募
不适用
Outcomes following a Multimodal Pain Protocol in Total Knee ArthroplastyTotal knee arthroplasty post operative pain and mobilitySurgery - Other surgeryMusculoskeletal - OsteoarthritisACTRN12612000343808Dr Gerald Yeo100
尚未招募
不适用
ong-Term Follow-Up of Patients who have received an Autologous Antigen-Specific Chimeric Antigen Receptor T Regulatory Cell Therapy (TX200-TR101) in a prior clinical study.Renal transplant rejectionAllograft rejection1002766510029149NL-OMON56013Sangamo Therapeutics France SAS8
进行中（未招募）
1 期
ong-Term Follow-Up of Patients who have received an Autologous Antigen-Specific Chimeric Antigen Receptor T Regulatory Cell Therapy (CAR- Treg therapy, TX200-TR101) in a prior clinical study.Prevention of immune mediated allograft rejection in patients with end-stage renal disease (ESRD) who are tissue typed as HLA-A*02 negative and have received a kidney transplant from an HLA-A*02 positive living donor.MedDRA version: 21.1Level: LLTClassification code 10050436Term: Prophylaxis against renal transplant rejectionSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2022-002440-40-DESangamo Therapeutics France SAS15